Clinical trials referenced in this document:
Documents that mention this clinical trial
Low-frequency STN-DBS provides acute gait improvements in Parkinson’s disease: a double-blinded randomised cross-over feasibility trial
Received: 25 March 2021
Accepted: 2 August 2021
First Online: 10 August 2021
: The methods and procedures for this study were considered and approved by the Australian Catholic University’s Human Research Ethics Committee (2017-155H) and all volunteers provided written informed consent prior to participation.
: Not applicable.
: The authors declare that they have no competing interests.